[1] CHEN Y, LIU Y, LUO C, et al. Analysis of multiple factors involved in acute progressive cerebral infarction and extra- and intracranial arterial lesions[J]. Exp Ther Med, 2014, 7(6): 1495. doi: 10.3892/etm.2014.1624
[2] MILLÁN M, REMOLLO S, QUESADA H, et al. Vessel patency at 24 hours and its relationship with clinical outcomes and infarct volume in REVASCAT trial(randomized trial of revascularization with solitaire FR device versus best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight hours of symptom onset)[J]. Stroke, 2017, 48(4): 983. doi: 10.1161/STROKEAHA.116.015455
[3] YANG Y, XUE T, ZHU J, et al. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction[J]. Clin Neurol Neurosurg, 2017, 160: 40. doi: 10.1016/j.clineuro.2017.06.007
[4] XUE QZ, MENG AG, WANG T, et al. Correlation between of small dense low-density lipoprotein cholesterol with acute cerebral infarction and carotid atherosclerotic plaque stability[J]. J Clin Lab Anal, 2019, 33(6): e22891.
[5] GREISENEGGER S, ENDLER G, HSIEH K, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events[J]. Stroke, 2004, 35(7): 1688. doi: 10.1161/01.STR.0000130512.81212.a2
[6] LIN CY, CHANG CY, SUN CH, et al. Platelet count and early outcome in patients with spontaneous cerebellar hemorrhage: a retrospective study[J]. PLoS One, 2015, 10(3): e0119109. doi: 10.1371/journal.pone.0119109
[7] PARK MG, KIM MK, CHAE SH, et al. Lymphocyte-to-monocyte ratio on day 7 is associated with outcomes in acute ischemic stroke[J]. Neurol Sci, 2018, 39(2): 243. doi: 10.1007/s10072-017-3163-7
[8] REN X, AKIYOSHI K, DZIENNIS S, et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke[J]. J Neurosci, 2011, 31(23): 8556. doi: 10.1523/JNEUROSCI.1623-11.2011
[9] LIESZ A, SURI-PAYER E, VELTKAMP C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke[J]. Nat Med, 2009, 15(2): 192. doi: 10.1038/nm.1927
[10] KILIC A, KURTUL A. RETRACTED: Mean platelet volume-to-lymphocyte ratio as a novel marker for severity and complexity of coronary atherosclerosis in patients with acute coronary syndrome[J]. Angiology, 2017: 3319717724274.
[11] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666. doi: 10.3760/cma.j.issn.1006-7876.2018.09.004
[12] 王伊龙, 赵性泉, 刘新峰, 等. 高危非致残性缺血性脑血管事件诊疗指南[J]. 中国卒中杂志, 2016, 11(6): 481. doi: 10.3969/j.issn.1673-5765.2016.06.011
[13] BARON T, BESKOW A, JAMES S, et al. Biobank linked to SWEDEHEART quality registry-routine blood sample collection opens new opportunities for cardiovascular research[J]. Ups J Med Sci, 2019, 124(1): 12. doi: 10.1080/03009734.2018.1498957
[14] MO L, CHEN Y, LI Z, et al. Red blood cell distribution width as a marker of cerebral infarction in hemodialysis patients[J]. Ren Fail, 2017, 39(1): 712. doi: 10.1080/0886022X.2017.1398664
[15] LIEN LM, LIN KH, HUANG LT, et al. Licochalcone a prevents platelet activation and thrombus formation through the inhibition of PLCγ2-PKC, Akt, and MAPK pathways[J]. Int J Mol Sci, 2017, 18(7): 1500. doi: 10.3390/ijms18071500
[16] KURTUL A, ACIKGOZ SK. Usefulness of mean platelet volume-to-lymphocyte ratio for predicting angiographic no-reflow and short-term prognosis after primary percutaneous coronary intervention in patients with st-segment elevation myocardial infarction[J]. Am J Cardiol, 2017, 120(4): 534. doi: 10.1016/j.amjcard.2017.05.020
[17] HUDZIK B, SZKODZIŃSKI J, LEKSTON A, et al. Mean platelet volume-to-lymphocyte ratio: a novel marker of poor short- and long-term prognosis in patients with diabetes mellitus and acute myocardial infarction[J]. J Diabetes Complications, 2016, 30(6): 1097. doi: 10.1016/j.jdiacomp.2016.04.010
[18] STEGNER D, KLAUS V, NIESWANDT B. Platelets as modulators of cerebral ischemia/reperfusion injury[J]. Front Immunol, 2019, 10: 2505. doi: 10.3389/fimmu.2019.02505
[19] JENNINGS LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis[J]. Thromb Haemost, 2009, 102(2): 248.
[20] CHEN SY, LIN YS, CHENG YF, et al. Mean platelet volume-to-lymphocyte ratio predicts poor functional outcomes among ischemic stroke patients treated with intravenous thrombolysis[J]. Front Neurol, 2019, 10: 1274. doi: 10.3389/fneur.2019.01274
[21] 李玲玲, 李永娟, 陈志斌. 急性脑梗死严重程度的影响因素及与淋巴细胞/单核细胞比值的关系[J]. 中国医学导报, 2018, 15(26): 62.
[22] CHAUHAN A, HUDOBENKO J, Al MAMUN A, et al. Myeloid-specific TAK1 deletion results in reduced brain monocyte infiltration and improved outcomes after stroke[J]. J Neuroinflammation, 2018, 15(1): 148. doi: 10.1186/s12974-018-1188-3